NEOPHARM INC (NEOL) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 59 transactions totaling $3.0M, demonstrating a bullish sentiment with $2.9M in net insider flow. The most recent transaction on Jun 5, 2008 involved a purchase of 11,500 shares valued at $9.5K.
No significant insider buying has been recorded for NEOL in the recent period.
No significant insider selling has been recorded for NEOL in the recent period.
Based on recent SEC filings, insider sentiment for NEOL is bullish with an Insider Alignment Score of 98/100 and a net flow of $2.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at NEOPHARM INC (NEOL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading NEOL stock, having executed 59 transactions in the past 90 days. The most active insider is John N. Kapoor (Executive), who has made 24 transactions totaling $2.6M.
Get notified when executives and directors at NEOL file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 5, 2008 | N. Kapoor John | Executive | Purchase | 11,500 | $0.83 | $9.5K | |
| Jun 4, 2008 | N. Kapoor John | Executive | Purchase | 25,000 | $0.72 | $18.0K | |
| Jun 3, 2008 | N. Kapoor John | Executive | Purchase | 20,000 | $0.69 | $13.8K | |
| Jun 2, 2008 | N. Kapoor John | Executive | Purchase | 28,500 | $0.67 | $19.1K | |
| Jun 2, 2008 | Ali Shahid | Executive | Purchase | 5,000 | $0.62 | $3.1K | |
| May 30, 2008 | A. Fox Bernard | Executive | Purchase | 4,000 | $0.61 | $2.4K | |
| May 30, 2008 | N. Kapoor John | Executive | Purchase | 9,600 | $0.61 | $5.9K | |
| May 29, 2008 | N. Kapoor John | Executive | Purchase | 400 | $0.58 | $232 | |
| May 28, 2008 | N. Kapoor John | Executive | Purchase | 30,000 | $0.59 | $17.7K | |
| May 27, 2008 | Birch Laurence | Executive | Purchase | 9,000 | $0.59 | $5.3K | |
| May 27, 2008 | Birch Laurence | Executive | Purchase | 1,000 | $0.59 | $590 | |
| Nov 15, 2007 | C. Becker Frank | Executive | Sale | 33,000 | $0.88 | $29.0K | |
| Aug 16, 2007 | E. Freiman Paul | Executive | Award | 50,761 | $N/A | $0 | |
| Aug 16, 2007 | A. Fox Bernard | Executive | Award | 50,761 | $N/A | $0 | |
| Aug 16, 2007 | C. Becker Frank | Executive | Award | 50,761 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 33 | $2.9M | 98.0% |
Sale(S) | 3 | $60.0K | 2.0% |
Award(A) | 23 | $0 | 0.0% |
Insiders at NEOPHARM INC are accumulating shares at an accelerated pace. With 13 insiders making 59 transactions totaling $2.9M in purchases versus $60.0K in sales, the net buying activity of $2.9M signals strong executive confidence. John N. Kapoor (Executive) leads the buying activity with $2.6M in transactions across all time.